Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 438

1.

Charlson Comorbidity Index Based On Hospital Episode Statistics Performs Adequately In Predicting Mortality, But Its Discriminative Ability Diminishes Over Time.

Pylväläinen J, Talala K, Murtola T, Taari K, Raitanen J, Tammela TL, Auvinen A.

Clin Epidemiol. 2019 Oct 18;11:923-932. doi: 10.2147/CLEP.S218697. eCollection 2019.

2.

Cost-effectiveness analysis of PSA-based mass screening: Evidence from a randomised controlled trial combined with register data.

Booth N, Rissanen P, Tammela TLJ, Kujala P, Stenman UH, Taari K, Talala K, Auvinen A.

PLoS One. 2019 Nov 5;14(11):e0224479. doi: 10.1371/journal.pone.0224479. eCollection 2019.

3.

Clinical and epidemiological observations on individual radiation sensitivity and susceptibility.

Seibold P, Auvinen A, Averbeck D, Bourguignon M, Hartikainen JM, Hoeschen C, Laurent O, Noël G, Sabatier L, Salomaa S, Blettner M.

Int J Radiat Biol. 2019 Sep 20:1-16. doi: 10.1080/09553002.2019.1665209. [Epub ahead of print]

PMID:
31539290
4.

The Impact of Nocturia on Mortality: A Systematic Review and Meta-Analysis.

Pesonen JS, Cartwright R, Vernooij RWM, Aoki Y, Agarwal A, Mangera A, Markland AD, Tsui JF, Santti H, Griebling TL, Pryalukhin AE, Riikonen J, Tähtinen RM, Vaughan CP, Johnson TM 2nd, Auvinen A, Heels-Ansdell D, Guyatt GH, Tikkinen KAO.

J Urol. 2019 Jul 31:101097JU0000000000000463. doi: 10.1097/JU.0000000000000463. [Epub ahead of print]

PMID:
31364920
5.

Parental occupational exposure to low-frequency magnetic fields and risk of leukaemia in the offspring: findings from the Childhood Leukaemia International Consortium (CLIC).

Talibov M, Olsson A, Bailey H, Erdmann F, Metayer C, Magnani C, Petridou E, Auvinen A, Spector L, Clavel J, Roman E, Dockerty J, Nikkilä A, Lohi O, Kang A, Psaltopoulou T, Miligi L, Vila J, Cardis E, Schüz J.

Occup Environ Med. 2019 Oct;76(10):746-753. doi: 10.1136/oemed-2019-105706. Epub 2019 Jul 29.

6.

Washington State's Fruit and Vegetable Prescription Program: Improving Affordability of Healthy Foods for Low-Income Patients.

Marcinkevage J, Auvinen A, Nambuthiri S.

Prev Chronic Dis. 2019 Jul 18;16. doi: 10.5888/pcd16.180617.

7.

Productivity losses associated with premature mortality due to cancer in Russia: A population-wide study covering 2001-2030.

Barchuk A, Bespalov A, Huhtala H, Chimed T, Belyaev A, Moore M, Anttila A, Auvinen A, Pearce A, Soerjomataram I.

Scand J Public Health. 2019 Jul;47(5):482-491. doi: 10.1177/1403494819845565.

8.

Headache, tinnitus and hearing loss in the international Cohort Study of Mobile Phone Use and Health (COSMOS) in Sweden and Finland.

Auvinen A, Feychting M, Ahlbom A, Hillert L, Elliott P, Schüz J, Kromhout H, Toledano MB, Johansen C, Poulsen AH, Vermeulen R, Heinävaara S, Kojo K, Tettamanti G; COSMOS Study Group .

Int J Epidemiol. 2019 Jul 13. pii: dyz127. doi: 10.1093/ije/dyz127. [Epub ahead of print]

9.

Anticoagulants and cancer mortality in the Finnish randomized study of screening for prostate cancer.

Kinnunen PTT, Murtola TJ, Talala K, Taari K, Tammela TLJ, Auvinen A.

Cancer Causes Control. 2019 Aug;30(8):877-888. doi: 10.1007/s10552-019-01195-x. Epub 2019 Jun 17.

PMID:
31209595
10.

Consistent Biopsy Quality and Gleason Grading Within the Global Active Surveillance Global Action Plan 3 Initiative: A Prerequisite for Future Studies.

van der Kwast TH, Helleman J, Nieboer D, Bruinsma SM, Roobol MJ; Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium, Trock B, Ehdaie B, Carroll P, Filson C, Kim J, Logothetis C, Morgan T, Klotz L, Pickles T, Hyndman E, Moore CM, Gnanapragasam V, Van Hemelrijck M, Dasgupta P, Bangma C, Roobol M, Villers A, Rannikko A, Valdagni R, Perry A, Hugosson J, Rubio-Briones J, Bjartell A, Hefermehl L, Shiong LL, Frydenberg M, Kakehi Y, Chung BH, van der Kwast T, Obbink H, van der Linden W, Hulsen T, de Jonge C, Kattan M, Xinge J, Muir K, Lophatananon A, Fahey M, Steyerberg E, Nieboer D, Zhang L, Guo W, Benfante N, Cowan J, Patil D, Tolosa E, Kim TK, Mamedov A, LaPointe V, Crump T, Kimberly-Duffell J, Santaolalla A, Nieboer D, Olivier JT, Rancati T, Ahlgren H, Mascarós J, Löfgren A, Lehmann K, Lin CH, Hirama H, Lee KS, Jenster G, Auvinen A, Bjartell A, Haider M, van Bochove K, Carter B, Gledhill S, Buzza M, Bangma C, Roobol M, Bruinsma S, Helleman J.

Eur Urol Oncol. 2019 May;2(3):333-336. doi: 10.1016/j.euo.2018.08.017. Epub 2018 Sep 13.

PMID:
31200849
11.

Fertility and marital status in adults with childhood onset epilepsy: A population-based cohort study.

Starck C, Nevalainen O, Auvinen A, Eriksson K.

Epilepsia. 2019 Jul;60(7):1438-1444. doi: 10.1111/epi.16018. Epub 2019 May 23.

PMID:
31121078
12.

The Impact of Design and Performance in Prostate-Specific Antigen Screening: Differences Between ERSPC Centers.

Heijnsdijk EAM, Adolfsson J, Auvinen A, Roobol MJ, Hugosson J, de Koning HJ.

Eur Urol. 2019 Sep;76(3):276-279. doi: 10.1016/j.eururo.2019.04.007. Epub 2019 Apr 26.

PMID:
31031050
13.

Incidence trends of adult malignant brain tumors in Finland, 1990-2016.

Natukka T, Raitanen J, Haapasalo H, Auvinen A.

Acta Oncol. 2019 Jul;58(7):990-996. doi: 10.1080/0284186X.2019.1603396. Epub 2019 Apr 15.

PMID:
30985227
14.

Could Differences in Treatment Between Trial Arms Explain the Reduction in Prostate Cancer Mortality in the European Randomized Study of Screening for Prostate Cancer?

Carlsson SV, Månsson M, Moss S, Kwiatkowski M, Recker F, Tammela TLJ, Bangma C, Roobol MJ, Auvinen A, Hugosson J.

Eur Urol. 2019 Jun;75(6):1015-1022. doi: 10.1016/j.eururo.2019.03.010. Epub 2019 Mar 28.

PMID:
30928162
15.

A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer.

Hugosson J, Roobol MJ, Månsson M, Tammela TLJ, Zappa M, Nelen V, Kwiatkowski M, Lujan M, Carlsson SV, Talala KM, Lilja H, Denis LJ, Recker F, Paez A, Puliti D, Villers A, Rebillard X, Kilpeläinen TP, Stenman UH, Godtman RA, Stinesen Kollberg K, Moss SM, Kujala P, Taari K, Huber A, van der Kwast T, Heijnsdijk EA, Bangma C, De Koning HJ, Schröder FH, Auvinen A; ERSPC investigators.

Eur Urol. 2019 Jul;76(1):43-51. doi: 10.1016/j.eururo.2019.02.009. Epub 2019 Feb 26.

PMID:
30824296
16.

Parental age and the risk of childhood acute myeloid leukemia: results from the Childhood Leukemia International Consortium.

Panagopoulou P, Skalkidou A, Marcotte E, Erdmann F, Ma X, Heck JE, Auvinen A, Mueller BA, Spector LG, Roman E, Metayer C, Magnani C, Pombo-de-Oliveira MS, Scheurer ME, Mora AM, Dockerty JD, Hansen J, Kang AY, Wang R, Doody DR, Kane E, Schüz J, Christodoulakis C, Ntzani E, Petridou ET; FRECCLE group; NARECHEM-ST group.

Cancer Epidemiol. 2019 Apr;59:158-165. doi: 10.1016/j.canep.2019.01.022. Epub 2019 Feb 15.

PMID:
30776582
17.

Antihypertensive drugs and prostate cancer risk in a Finnish population-based cohort.

Siltari A, Murtola TJ, Talala K, Taari K, Tammela TLJ, Auvinen A.

Scand J Urol. 2018 Oct - Dec;52(5-6):321-327. doi: 10.1080/21681805.2018.1559882. Epub 2019 Jan 30.

PMID:
30698056
18.

Allopurinol and the risk of prostate cancer in a Finnish population-based cohort.

Kukko V, Kaipia A, Talala K, Taari K, Tammela TLJ, Auvinen A, Murtola TJ.

Prostate Cancer Prostatic Dis. 2019 Sep;22(3):483-490. doi: 10.1038/s41391-019-0129-2. Epub 2019 Jan 29.

PMID:
30696944
19.

Blood glucose, glucose balance, and disease-specific survival after prostate cancer diagnosis in the Finnish Randomized Study of Screening for Prostate Cancer.

Murtola TJ, Sälli SM, Talala K, Taari K, Tammela TLJ, Auvinen A.

Prostate Cancer Prostatic Dis. 2019 Sep;22(3):453-460. doi: 10.1038/s41391-018-0123-0. Epub 2019 Jan 24.

PMID:
30679762
20.

Bias-corrected estimates of effects of PSA screening decisions on the risk of prostate cancer diagnosis and death: Analysis of the Finnish randomized study of screening for prostate cancer.

Lindberg A, Talala K, Kujala P, Stenman UH, Taari K, Kilpeläinen TP, Tammela TL, Auvinen A.

Int J Cancer. 2019 Aug 1;145(3):632-638. doi: 10.1002/ijc.32129. Epub 2019 Feb 4.

PMID:
30653262
21.

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.

Schumacher FR, Olama AAA, Berndt SI, Benlloch S, Ahmed M, Saunders EJ, Dadaev T, Leongamornlert D, Anokian E, Cieza-Borrella C, Goh C, Brook MN, Sheng X, Fachal L, Dennis J, Tyrer J, Muir K, Lophatananon A, Stevens VL, Gapstur SM, Carter BD, Tangen CM, Goodman PJ, Thompson IM Jr, Batra J, Chambers S, Moya L, Clements J, Horvath L, Tilley W, Risbridger GP, Gronberg H, Aly M, Nordström T, Pharoah P, Pashayan N, Schleutker J, Tammela TLJ, Sipeky C, Auvinen A, Albanes D, Weinstein S, Wolk A, Håkansson N, West CML, Dunning AM, Burnet N, Mucci LA, Giovannucci E, Andriole GL, Cussenot O, Cancel-Tassin G, Koutros S, Beane Freeman LE, Sorensen KD, Orntoft TF, Borre M, Maehle L, Grindedal EM, Neal DE, Donovan JL, Hamdy FC, Martin RM, Travis RC, Key TJ, Hamilton RJ, Fleshner NE, Finelli A, Ingles SA, Stern MC, Rosenstein BS, Kerns SL, Ostrer H, Lu YJ, Zhang HW, Feng N, Mao X, Guo X, Wang G, Sun Z, Giles GG, Southey MC, MacInnis RJ, FitzGerald LM, Kibel AS, Drake BF, Vega A, Gómez-Caamaño A, Szulkin R, Eklund M, Kogevinas M, Llorca J, Castaño-Vinyals G, Penney KL, Stampfer M, Park JY, Sellers TA, Lin HY, Stanford JL, Cybulski C, Wokolorczyk D, Lubinski J, Ostrander EA, Geybels MS, Nordestgaard BG, Nielsen SF, Weischer M, Bisbjerg R, Røder MA, Iversen P, Brenner H, Cuk K, Holleczek B, Maier C, Luedeke M, Schnoeller T, Kim J, Logothetis CJ, John EM, Teixeira MR, Paulo P, Cardoso M, Neuhausen SL, Steele L, Ding YC, De Ruyck K, De Meerleer G, Ost P, Razack A, Lim J, Teo SH, Lin DW, Newcomb LF, Lessel D, Gamulin M, Kulis T, Kaneva R, Usmani N, Singhal S, Slavov C, Mitev V, Parliament M, Claessens F, Joniau S, Van den Broeck T, Larkin S, Townsend PA, Aukim-Hastie C, Gago-Dominguez M, Castelao JE, Martinez ME, Roobol MJ, Jenster G, van Schaik RHN, Menegaux F, Truong T, Koudou YA, Xu J, Khaw KT, Cannon-Albright L, Pandha H, Michael A, Thibodeau SN, McDonnell SK, Schaid DJ, Lindstrom S, Turman C, Ma J, Hunter DJ, Riboli E, Siddiq A, Canzian F, Kolonel LN, Le Marchand L, Hoover RN, Machiela MJ, Cui Z, Kraft P, Amos CI, Conti DV, Easton DF, Wiklund F, Chanock SJ, Henderson BE, Kote-Jarai Z, Haiman CA, Eeles RA; Profile Study; Australian Prostate Cancer BioResource (APCB); IMPACT Study; Canary PASS Investigators; Breast and Prostate Cancer Cohort Consortium (BPC3); PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium; Cancer of the Prostate in Sweden (CAPS); Prostate Cancer Genome-wide Association Study of Uncommon Susceptibility Loci (PEGASUS); Genetic Associations and Mechanisms in Oncology (GAME-ON)/Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE) Consortium.

Nat Genet. 2019 Feb;51(2):363. doi: 10.1038/s41588-018-0330-6.

PMID:
30622367
22.

Exposure to loud noise and risk of vestibular schwannoma: results from the INTERPHONE international case‒control study.

Deltour I, Schlehofer B, Massardier-Pilonchéry A, Schlaefer K, Armstrong B, Giles GG, Siemiatycki J, Parent ME, Krewski D, McBride M, Johansen C, Auvinen A, Salminen T, Hours M, Montestrucq L, Blettner M, Berg-Beckhoff G, Sadetzki S, Chetrit A, Lagorio S, Iavarone I, Yamaguchi N, Takebayashi T, Woodward A, Cook A, Tynes T, Klaeboe L, Maria Feychting MF, Lönn S, Fleming S, Swerdlow AJ, Schoemaker MJ, Moissonnier M, Kesminiene A, Cardis E, Schüz J; INTERPHONE Study Group.

Scand J Work Environ Health. 2019 Mar 1;45(2):183-193. doi: 10.5271/sjweh.3781. Epub 2018 Nov 5.

PMID:
30614502
23.

Survival of glioma patients in relation to mobile phone use in Denmark, Finland and Sweden.

Olsson A, Bouaoun L, Auvinen A, Feychting M, Johansen C, Mathiesen T, Melin B, Lahkola A, Larjavaara S, Villegier AS, Byrnes G, Deltour I, Schüz J.

J Neurooncol. 2019 Jan;141(1):139-149. doi: 10.1007/s11060-018-03019-5. Epub 2018 Nov 12.

PMID:
30421160
24.

Impact of lower urinary tract symptoms on mortality: a 21-year follow-up among middle-aged and elderly Finnish men.

Åkerla J, Pesonen JS, Pöyhönen A, Häkkinen J, Koskimäki J, Huhtala H, Tammela TLJ, Auvinen A.

Prostate Cancer Prostatic Dis. 2019 May;22(2):317-323. doi: 10.1038/s41391-018-0108-z. Epub 2018 Nov 8.

PMID:
30410016
25.

Severity and bother of lower urinary tract symptoms among men aged 30-80 years: Tampere Ageing Male Urological Study (TAMUS).

Pöyhönen A, Åkerla J, Häkkinen JT, Koskimäki J, Tammela TLJ, Auvinen A.

Scand J Urol. 2018 Aug;52(4):296-301. doi: 10.1080/21681805.2018.1505944. Epub 2018 Nov 1.

PMID:
30382800
26.

Risk Prediction of Prostate Cancer with Single Nucleotide Polymorphisms and Prostate Specific Antigen.

Li-Sheng Chen S, Ching-Yuan Fann J, Sipeky C, Yang TK, Yueh-Hsia Chiu S, Ming-Fang Yen A, Laitinen V, Tammela TLJ, Stenman UH, Auvinen A, Schleutker J, Chen HH.

J Urol. 2019 Mar;201(3):486-495. doi: 10.1016/j.juro.2018.10.015.

PMID:
30366021
27.

The Number of Screening Cycles Needed to Reduce Prostate Cancer Mortality in the Finnish Section of the European Randomized Study of Prostate Cancer (ERSPC).

Pakarainen T, Nevalainen J, Talala K, Taari K, Raitanen J, Kujala P, Stenman UH, Tammela TLJ, Auvinen A.

Clin Cancer Res. 2019 Jan 15;25(2):839-843. doi: 10.1158/1078-0432.CCR-18-1807. Epub 2018 Oct 15.

PMID:
30322875
28.

Excess mortality in Finnish diabetic subjects due to alcohol, accidents and suicide: a nationwide study

Niskanen L, Partonen T, Auvinen A, Haukka J.

Eur J Endocrinol. 2018 Oct 12;179(5):299-306. doi: 10.1530/EJE-18-0351.

PMID:
30320503
29.

Long-term strategies for thyroid health monitoring after nuclear accidents: recommendations from an Expert Group convened by IARC.

Togawa K, Ahn HS, Auvinen A, Bauer AJ, Brito JP, Davies L, Kesminiene A, Laurier D, Ostroumova E, Pacini F, Reiners C, Shinkarev S, Thomas G, Tronko M, Vaccarella S, Schüz J.

Lancet Oncol. 2018 Oct;19(10):1280-1283. doi: 10.1016/S1470-2045(18)30680-6. Epub 2018 Oct 1. No abstract available.

PMID:
30303113
30.

Serum cholesterol and prostate cancer risk in the Finnish randomized study of screening for prostate cancer.

Murtola TJ, Kasurinen TVJ, Talala K, Taari K, Tammela TLJ, Auvinen A.

Prostate Cancer Prostatic Dis. 2019 Mar;22(1):66-76. doi: 10.1038/s41391-018-0087-0. Epub 2018 Sep 13.

PMID:
30214034
31.

Synergistic Interaction of HOXB13 and CIP2A Predisposes to Aggressive Prostate Cancer.

Sipeky C, Gao P, Zhang Q, Wang L, Ettala O, Talala KM, Tammela TLJ, Auvinen A, Wiklund F, Wei GH, Schleutker J.

Clin Cancer Res. 2018 Dec 15;24(24):6265-6276. doi: 10.1158/1078-0432.CCR-18-0444. Epub 2018 Sep 4.

32.

Biology and Clinical Implications of the 19q13 Aggressive Prostate Cancer Susceptibility Locus.

Gao P, Xia JH, Sipeky C, Dong XM, Zhang Q, Yang Y, Zhang P, Cruz SP, Zhang K, Zhu J, Lee HM, Suleman S, Giannareas N, Liu S; PRACTICAL Consortium, Tammela TLJ, Auvinen A, Wang X, Huang Q, Wang L, Manninen A, Vaarala MH, Wang L, Schleutker J, Wei GH.

Cell. 2018 Jul 26;174(3):576-589.e18. doi: 10.1016/j.cell.2018.06.003. Epub 2018 Jul 19.

33.

Cancer mortality does not differ by antiarrhythmic drug use: A population-based cohort of Finnish men.

Kaapu KJ, Rantaniemi L, Talala K, Taari K, Tammela TLJ, Auvinen A, Murtola TJ.

Sci Rep. 2018 Jul 9;8(1):10308. doi: 10.1038/s41598-018-28541-4.

34.

Bayesian negative-binomial-family-based multistate Markov model for the evaluation of periodic population-based cancer screening considering incomplete information and measurement errors.

Hsu CY, Yen MF, Auvinen A, Chiu YH, Chen HH.

Stat Methods Med Res. 2018 Aug;27(8):2519-2539. doi: 10.1177/0962280216682284. Epub 2016 Dec 15.

PMID:
29984633
35.

Radiation exposure from computerized tomography and risk of childhood leukemia: Finnish register-based case-control study of childhood leukemia (FRECCLE).

Nikkilä A, Raitanen J, Lohi O, Auvinen A.

Haematologica. 2018 Nov;103(11):1873-1880. doi: 10.3324/haematol.2018.187716. Epub 2018 Jul 5.

36.

Effects of incomplete residential histories on studies of environmental exposure with application to childhood leukaemia and background radiation.

Nikkilä A, Kendall G, Raitanen J, Spycher B, Lohi O, Auvinen A.

Environ Res. 2018 Oct;166:466-472. doi: 10.1016/j.envres.2018.06.035. Epub 2018 Jun 23.

PMID:
29945121
37.

Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.

Dadaev T, Saunders EJ, Newcombe PJ, Anokian E, Leongamornlert DA, Brook MN, Cieza-Borrella C, Mijuskovic M, Wakerell S, Olama AAA, Schumacher FR, Berndt SI, Benlloch S, Ahmed M, Goh C, Sheng X, Zhang Z, Muir K, Govindasami K, Lophatananon A, Stevens VL, Gapstur SM, Carter BD, Tangen CM, Goodman P, Thompson IM Jr, Batra J, Chambers S, Moya L, Clements J, Horvath L, Tilley W, Risbridger G, Gronberg H, Aly M, Nordström T, Pharoah P, Pashayan N, Schleutker J, Tammela TLJ, Sipeky C, Auvinen A, Albanes D, Weinstein S, Wolk A, Hakansson N, West C, Dunning AM, Burnet N, Mucci L, Giovannucci E, Andriole G, Cussenot O, Cancel-Tassin G, Koutros S, Freeman LEB, Sorensen KD, Orntoft TF, Borre M, Maehle L, Grindedal EM, Neal DE, Donovan JL, Hamdy FC, Martin RM, Travis RC, Key TJ, Hamilton RJ, Fleshner NE, Finelli A, Ingles SA, Stern MC, Rosenstein B, Kerns S, Ostrer H, Lu YJ, Zhang HW, Feng N, Mao X, Guo X, Wang G, Sun Z, Giles GG, Southey MC, MacInnis RJ, FitzGerald LM, Kibel AS, Drake BF, Vega A, Gómez-Caamaño A, Fachal L, Szulkin R, Eklund M, Kogevinas M, Llorca J, Castaño-Vinyals G, Penney KL, Stampfer M, Park JY, Sellers TA, Lin HY, Stanford JL, Cybulski C, Wokolorczyk D, Lubinski J, Ostrander EA, Geybels MS, Nordestgaard BG, Nielsen SF, Weisher M, Bisbjerg R, Røder MA, Iversen P, Brenner H, Cuk K, Holleczek B, Maier C, Luedeke M, Schnoeller T, Kim J, Logothetis CJ, John EM, Teixeira MR, Paulo P, Cardoso M, Neuhausen SL, Steele L, Ding YC, De Ruyck K, De Meerleer G, Ost P, Razack A, Lim J, Teo SH, Lin DW, Newcomb LF, Lessel D, Gamulin M, Kulis T, Kaneva R, Usmani N, Slavov C, Mitev V, Parliament M, Singhal S, Claessens F, Joniau S, Van den Broeck T, Larkin S, Townsend PA, Aukim-Hastie C, Gago-Dominguez M, Castelao JE, Martinez ME, Roobol MJ, Jenster G, van Schaik RHN, Menegaux F, Truong T, Koudou YA, Xu J, Khaw KT, Cannon-Albright L, Pandha H, Michael A, Kierzek A, Thibodeau SN, McDonnell SK, Schaid DJ, Lindstrom S, Turman C, Ma J, Hunter DJ, Riboli E, Siddiq A, Canzian F, Kolonel LN, Le Marchand L, Hoover RN, Machiela MJ, Kraft P; PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium, Freedman M, Wiklund F, Chanock S, Henderson BE, Easton DF, Haiman CA, Eeles RA, Conti DV, Kote-Jarai Z.

Nat Commun. 2018 Jun 11;9(1):2256. doi: 10.1038/s41467-018-04109-8.

38.

Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.

Schumacher FR, Al Olama AA, Berndt SI, Benlloch S, Ahmed M, Saunders EJ, Dadaev T, Leongamornlert D, Anokian E, Cieza-Borrella C, Goh C, Brook MN, Sheng X, Fachal L, Dennis J, Tyrer J, Muir K, Lophatananon A, Stevens VL, Gapstur SM, Carter BD, Tangen CM, Goodman PJ, Thompson IM Jr, Batra J, Chambers S, Moya L, Clements J, Horvath L, Tilley W, Risbridger GP, Gronberg H, Aly M, Nordström T, Pharoah P, Pashayan N, Schleutker J, Tammela TLJ, Sipeky C, Auvinen A, Albanes D, Weinstein S, Wolk A, Håkansson N, West CML, Dunning AM, Burnet N, Mucci LA, Giovannucci E, Andriole GL, Cussenot O, Cancel-Tassin G, Koutros S, Beane Freeman LE, Sorensen KD, Orntoft TF, Borre M, Maehle L, Grindedal EM, Neal DE, Donovan JL, Hamdy FC, Martin RM, Travis RC, Key TJ, Hamilton RJ, Fleshner NE, Finelli A, Ingles SA, Stern MC, Rosenstein BS, Kerns SL, Ostrer H, Lu YJ, Zhang HW, Feng N, Mao X, Guo X, Wang G, Sun Z, Giles GG, Southey MC, MacInnis RJ, FitzGerald LM, Kibel AS, Drake BF, Vega A, Gómez-Caamaño A, Szulkin R, Eklund M, Kogevinas M, Llorca J, Castaño-Vinyals G, Penney KL, Stampfer M, Park JY, Sellers TA, Lin HY, Stanford JL, Cybulski C, Wokolorczyk D, Lubinski J, Ostrander EA, Geybels MS, Nordestgaard BG, Nielsen SF, Weischer M, Bisbjerg R, Røder MA, Iversen P, Brenner H, Cuk K, Holleczek B, Maier C, Luedeke M, Schnoeller T, Kim J, Logothetis CJ, John EM, Teixeira MR, Paulo P, Cardoso M, Neuhausen SL, Steele L, Ding YC, De Ruyck K, De Meerleer G, Ost P, Razack A, Lim J, Teo SH, Lin DW, Newcomb LF, Lessel D, Gamulin M, Kulis T, Kaneva R, Usmani N, Singhal S, Slavov C, Mitev V, Parliament M, Claessens F, Joniau S, Van den Broeck T, Larkin S, Townsend PA, Aukim-Hastie C, Gago-Dominguez M, Castelao JE, Martinez ME, Roobol MJ, Jenster G, van Schaik RHN, Menegaux F, Truong T, Koudou YA, Xu J, Khaw KT, Cannon-Albright L, Pandha H, Michael A, Thibodeau SN, McDonnell SK, Schaid DJ, Lindstrom S, Turman C, Ma J, Hunter DJ, Riboli E, Siddiq A, Canzian F, Kolonel LN, Le Marchand L, Hoover RN, Machiela MJ, Cui Z, Kraft P, Amos CI, Conti DV, Easton DF, Wiklund F, Chanock SJ, Henderson BE, Kote-Jarai Z, Haiman CA, Eeles RA; Profile Study; Australian Prostate Cancer BioResource (APCB); IMPACT Study; Canary PASS Investigators; Breast and Prostate Cancer Cohort Consortium (BPC3); PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium; Cancer of the Prostate in Sweden (CAPS); Prostate Cancer Genome-wide Association Study of Uncommon Susceptibility Loci (PEGASUS); Genetic Associations and Mechanisms in Oncology (GAME-ON)/Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE) Consortium.

Nat Genet. 2018 Jul;50(7):928-936. doi: 10.1038/s41588-018-0142-8. Epub 2018 Jun 11. Erratum in: Nat Genet. 2019 Feb;51(2):363.

40.

Breast and cervical cancer incidence and mortality trends in Russia 1980-2013.

Barchuk A, Bespalov A, Huhtala H, Chimed T, Laricheva I, Belyaev A, Bray F, Anttila A, Auvinen A.

Cancer Epidemiol. 2018 Aug;55:73-80. doi: 10.1016/j.canep.2018.05.008. Epub 2018 May 26.

PMID:
29843073
41.

Advanced parental age as risk factor for childhood acute lymphoblastic leukemia: results from studies of the Childhood Leukemia International Consortium.

Petridou ET, Georgakis MK, Erdmann F, Ma X, Heck JE, Auvinen A, Mueller BA, Spector LG, Roman E, Metayer C, Magnani C, Pombo-de-Oliveira MS, Ezzat S, Scheurer ME, Mora AM, Dockerty JD, Hansen J, Kang AY, Wang R, Doody DR, Kane E, Rashed WM, Dessypris N, Schüz J, Infante-Rivard C, Skalkidou A.

Eur J Epidemiol. 2018 Oct;33(10):965-976. doi: 10.1007/s10654-018-0402-z. Epub 2018 May 14.

42.

Prostate cancer screening: what can we learn from randomised trials?

Auvinen A.

Transl Androl Urol. 2018 Feb;7(1):12-17. doi: 10.21037/tau.2017.12.13. Review.

43.

Fasting blood glucose, glycaemic control and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer.

Murtola TJ, Vihervuori VJ, Lahtela J, Talala K, Taari K, Tammela TL, Auvinen A.

Br J Cancer. 2018 May;118(9):1248-1254. doi: 10.1038/s41416-018-0055-4. Epub 2018 Mar 22.

44.

Costs of screening for prostate cancer: Evidence from the Finnish Randomised Study of Screening for Prostate Cancer after 20-year follow-up using register data.

Booth N, Rissanen P, Tammela TLJ, Taari K, Talala K, Auvinen A.

Eur J Cancer. 2018 Apr;93:108-118. doi: 10.1016/j.ejca.2018.01.111. Epub 2018 Mar 20.

PMID:
29501976
45.

Allopurinol and risk of benign prostatic hyperplasia in a Finnish population-based cohort.

Kukko V, Kaipia A, Talala K, Taari K, Tammela TLJ, Auvinen A, Murtola TJ.

Prostate Cancer Prostatic Dis. 2018 Sep;21(3):373-378. doi: 10.1038/s41391-017-0031-8. Epub 2017 Dec 22.

PMID:
29273728
46.

Multidisciplinary European Low Dose Initiative (MELODI): strategic research agenda for low dose radiation risk research.

Kreuzer M, Auvinen A, Cardis E, Durante M, Harms-Ringdahl M, Jourdain JR, Madas BG, Ottolenghi A, Pazzaglia S, Prise KM, Quintens R, Sabatier L, Bouffler S.

Radiat Environ Biophys. 2018 Mar;57(1):5-15. doi: 10.1007/s00411-017-0726-1. Epub 2017 Dec 15. Review.

47.

Prognostic factors of prostate cancer mortality in a Finnish randomized screening trial.

Neupane S, Steyerberg E, Raitanen J, Talala K, Pylväläinen J, Taari K, Tammela TL, Auvinen A.

Int J Urol. 2018 Mar;25(3):270-276. doi: 10.1111/iju.13508. Epub 2017 Dec 10.

48.

The efficacy of prostate-specific antigen screening: Impact of key components in the ERSPC and PLCO trials.

de Koning HJ, Gulati R, Moss SM, Hugosson J, Pinsky PF, Berg CD, Auvinen A, Andriole GL, Roobol MJ, Crawford ED, Nelen V, Kwiatkowski M, Zappa M, Luján M, Villers A, de Carvalho TM, Feuer EJ, Tsodikov A, Mariotto AB, Heijnsdijk EAM, Etzioni R.

Cancer. 2018 Mar 15;124(6):1197-1206. doi: 10.1002/cncr.31178. Epub 2017 Dec 6.

49.

A Four-kallikrein Panel and β-Microseminoprotein in Predicting High-grade Prostate Cancer on Biopsy: An Independent Replication from the Finnish Section of the European Randomized Study of Screening for Prostate Cancer.

Assel M, Sjöblom L, Murtola TJ, Talala K, Kujala P, Stenman UH, Taari K, Auvinen A, Vickers A, Visakorpi T, Tammela TL, Lilja H.

Eur Urol Focus. 2019 Jul;5(4):561-567. doi: 10.1016/j.euf.2017.11.002. Epub 2017 Nov 11.

PMID:
29137895
50.

An international prospective cohort study of mobile phone users and health (COSMOS): Factors affecting validity of self-reported mobile phone use.

Toledano MB, Auvinen A, Tettamanti G, Cao Y, Feychting M, Ahlbom A, Fremling K, Heinävaara S, Kojo K, Knowles G, Smith RB, Schüz J, Johansen C, Poulsen AH, Deltour I, Vermeulen R, Kromhout H, Elliott P, Hillert L.

Int J Hyg Environ Health. 2018 Jan;221(1):1-8. doi: 10.1016/j.ijheh.2017.09.008. Epub 2017 Sep 20.

Supplemental Content

Loading ...
Support Center